0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dutasteride Drug Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-0E18940
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Dutasteride Drug Market Research Report 2024
BUY CHAPTERS

Global Dutasteride Drug Market Research Report 2024

Code: QYRE-Auto-0E18940
Report
November 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dutasteride Drug Market

The global Dutasteride Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Dutasteride is a medication classified as a dual 5-alpha-reductase inhibitor, primarily used in the treatment of benign prostatic hyperplasia (BPH) and, in some cases, male pattern hair loss (androgenetic alopecia).
North American market for Dutasteride Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dutasteride Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dutasteride Drug include GSK, Waylis Therapeutics, Endo, Zydus, Aurobindo Pharma, Barr Pharmaceuticals, Chartwell, Amneal Pharmaceuticals, Strides Pharma, Acella Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dutasteride Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dutasteride Drug.
The Dutasteride Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Dutasteride Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dutasteride Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dutasteride Drug Market Report

Report Metric Details
Report Name Dutasteride Drug Market
Segment by Type
  • Single Drug
  • Combination Preparation
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, Waylis Therapeutics, Endo, Zydus, Aurobindo Pharma, Barr Pharmaceuticals, Chartwell, Amneal Pharmaceuticals, Strides Pharma, Acella Pharmaceuticals, Ascent Pharmaceuticals, Humanwell Puracap, Sichuan Gowell Pharmaceutical, Chengdu Suncadia Medicine, Qilu Pharmaceutical, Jiangsu Wangao Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dutasteride Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dutasteride Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Dutasteride Drug Market report?

Ans: The main players in the Dutasteride Drug Market are GSK, Waylis Therapeutics, Endo, Zydus, Aurobindo Pharma, Barr Pharmaceuticals, Chartwell, Amneal Pharmaceuticals, Strides Pharma, Acella Pharmaceuticals, Ascent Pharmaceuticals, Humanwell Puracap, Sichuan Gowell Pharmaceutical, Chengdu Suncadia Medicine, Qilu Pharmaceutical, Jiangsu Wangao Pharmaceutical

What are the Application segmentation covered in the Dutasteride Drug Market report?

Ans: The Applications covered in the Dutasteride Drug Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Dutasteride Drug Market report?

Ans: The Types covered in the Dutasteride Drug Market report are Single Drug, Combination Preparation

Recommended Reports

Urology and BPH

Androgens & Prostate

Alopecia & Dermatology

1 Dutasteride Drug Market Overview
1.1 Product Definition
1.2 Dutasteride Drug by Type
1.2.1 Global Dutasteride Drug Market Value Comparison by Type (2024-2030)
1.2.2 Single Drug
1.2.3 Combination Preparation
1.3 Dutasteride Drug by Application
1.3.1 Global Dutasteride Drug Market Value by Application (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Dutasteride Drug Market Size Estimates and Forecasts
1.4.1 Global Dutasteride Drug Revenue 2019-2030
1.4.2 Global Dutasteride Drug Sales 2019-2030
1.4.3 Global Dutasteride Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dutasteride Drug Market Competition by Manufacturers
2.1 Global Dutasteride Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dutasteride Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dutasteride Drug Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Dutasteride Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dutasteride Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dutasteride Drug, Product Type & Application
2.7 Global Key Manufacturers of Dutasteride Drug, Date of Enter into This Industry
2.8 Global Dutasteride Drug Market Competitive Situation and Trends
2.8.1 Global Dutasteride Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dutasteride Drug Players Market Share by Revenue
2.8.3 Global Dutasteride Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dutasteride Drug Market Scenario by Region
3.1 Global Dutasteride Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dutasteride Drug Sales by Region: 2019-2030
3.2.1 Global Dutasteride Drug Sales by Region: 2019-2024
3.2.2 Global Dutasteride Drug Sales by Region: 2025-2030
3.3 Global Dutasteride Drug Revenue by Region: 2019-2030
3.3.1 Global Dutasteride Drug Revenue by Region: 2019-2024
3.3.2 Global Dutasteride Drug Revenue by Region: 2025-2030
3.4 North America Dutasteride Drug Market Facts & Figures by Country
3.4.1 North America Dutasteride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dutasteride Drug Sales by Country (2019-2030)
3.4.3 North America Dutasteride Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dutasteride Drug Market Facts & Figures by Country
3.5.1 Europe Dutasteride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dutasteride Drug Sales by Country (2019-2030)
3.5.3 Europe Dutasteride Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dutasteride Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Dutasteride Drug Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dutasteride Drug Sales by Region (2019-2030)
3.6.3 Asia Pacific Dutasteride Drug Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dutasteride Drug Market Facts & Figures by Country
3.7.1 Latin America Dutasteride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dutasteride Drug Sales by Country (2019-2030)
3.7.3 Latin America Dutasteride Drug Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dutasteride Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Dutasteride Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dutasteride Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dutasteride Drug Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dutasteride Drug Sales by Type (2019-2030)
4.1.1 Global Dutasteride Drug Sales by Type (2019-2024)
4.1.2 Global Dutasteride Drug Sales by Type (2025-2030)
4.1.3 Global Dutasteride Drug Sales Market Share by Type (2019-2030)
4.2 Global Dutasteride Drug Revenue by Type (2019-2030)
4.2.1 Global Dutasteride Drug Revenue by Type (2019-2024)
4.2.2 Global Dutasteride Drug Revenue by Type (2025-2030)
4.2.3 Global Dutasteride Drug Revenue Market Share by Type (2019-2030)
4.3 Global Dutasteride Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dutasteride Drug Sales by Application (2019-2030)
5.1.1 Global Dutasteride Drug Sales by Application (2019-2024)
5.1.2 Global Dutasteride Drug Sales by Application (2025-2030)
5.1.3 Global Dutasteride Drug Sales Market Share by Application (2019-2030)
5.2 Global Dutasteride Drug Revenue by Application (2019-2030)
5.2.1 Global Dutasteride Drug Revenue by Application (2019-2024)
5.2.2 Global Dutasteride Drug Revenue by Application (2025-2030)
5.2.3 Global Dutasteride Drug Revenue Market Share by Application (2019-2030)
5.3 Global Dutasteride Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Dutasteride Drug Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Waylis Therapeutics
6.2.1 Waylis Therapeutics Company Information
6.2.2 Waylis Therapeutics Description and Business Overview
6.2.3 Waylis Therapeutics Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Waylis Therapeutics Dutasteride Drug Product Portfolio
6.2.5 Waylis Therapeutics Recent Developments/Updates
6.3 Endo
6.3.1 Endo Company Information
6.3.2 Endo Description and Business Overview
6.3.3 Endo Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Endo Dutasteride Drug Product Portfolio
6.3.5 Endo Recent Developments/Updates
6.4 Zydus
6.4.1 Zydus Company Information
6.4.2 Zydus Description and Business Overview
6.4.3 Zydus Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zydus Dutasteride Drug Product Portfolio
6.4.5 Zydus Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Company Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aurobindo Pharma Dutasteride Drug Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 Barr Pharmaceuticals
6.6.1 Barr Pharmaceuticals Company Information
6.6.2 Barr Pharmaceuticals Description and Business Overview
6.6.3 Barr Pharmaceuticals Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Barr Pharmaceuticals Dutasteride Drug Product Portfolio
6.6.5 Barr Pharmaceuticals Recent Developments/Updates
6.7 Chartwell
6.7.1 Chartwell Company Information
6.7.2 Chartwell Description and Business Overview
6.7.3 Chartwell Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Chartwell Dutasteride Drug Product Portfolio
6.7.5 Chartwell Recent Developments/Updates
6.8 Amneal Pharmaceuticals
6.8.1 Amneal Pharmaceuticals Company Information
6.8.2 Amneal Pharmaceuticals Description and Business Overview
6.8.3 Amneal Pharmaceuticals Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Amneal Pharmaceuticals Dutasteride Drug Product Portfolio
6.8.5 Amneal Pharmaceuticals Recent Developments/Updates
6.9 Strides Pharma
6.9.1 Strides Pharma Company Information
6.9.2 Strides Pharma Description and Business Overview
6.9.3 Strides Pharma Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Strides Pharma Dutasteride Drug Product Portfolio
6.9.5 Strides Pharma Recent Developments/Updates
6.10 Acella Pharmaceuticals
6.10.1 Acella Pharmaceuticals Company Information
6.10.2 Acella Pharmaceuticals Description and Business Overview
6.10.3 Acella Pharmaceuticals Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Acella Pharmaceuticals Dutasteride Drug Product Portfolio
6.10.5 Acella Pharmaceuticals Recent Developments/Updates
6.11 Ascent Pharmaceuticals
6.11.1 Ascent Pharmaceuticals Company Information
6.11.2 Ascent Pharmaceuticals Description and Business Overview
6.11.3 Ascent Pharmaceuticals Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Ascent Pharmaceuticals Dutasteride Drug Product Portfolio
6.11.5 Ascent Pharmaceuticals Recent Developments/Updates
6.12 Humanwell Puracap
6.12.1 Humanwell Puracap Company Information
6.12.2 Humanwell Puracap Description and Business Overview
6.12.3 Humanwell Puracap Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Humanwell Puracap Dutasteride Drug Product Portfolio
6.12.5 Humanwell Puracap Recent Developments/Updates
6.13 Sichuan Gowell Pharmaceutical
6.13.1 Sichuan Gowell Pharmaceutical Company Information
6.13.2 Sichuan Gowell Pharmaceutical Description and Business Overview
6.13.3 Sichuan Gowell Pharmaceutical Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sichuan Gowell Pharmaceutical Dutasteride Drug Product Portfolio
6.13.5 Sichuan Gowell Pharmaceutical Recent Developments/Updates
6.14 Chengdu Suncadia Medicine
6.14.1 Chengdu Suncadia Medicine Company Information
6.14.2 Chengdu Suncadia Medicine Description and Business Overview
6.14.3 Chengdu Suncadia Medicine Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Chengdu Suncadia Medicine Dutasteride Drug Product Portfolio
6.14.5 Chengdu Suncadia Medicine Recent Developments/Updates
6.15 Qilu Pharmaceutical
6.15.1 Qilu Pharmaceutical Company Information
6.15.2 Qilu Pharmaceutical Description and Business Overview
6.15.3 Qilu Pharmaceutical Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Qilu Pharmaceutical Dutasteride Drug Product Portfolio
6.15.5 Qilu Pharmaceutical Recent Developments/Updates
6.16 Jiangsu Wangao Pharmaceutical
6.16.1 Jiangsu Wangao Pharmaceutical Company Information
6.16.2 Jiangsu Wangao Pharmaceutical Description and Business Overview
6.16.3 Jiangsu Wangao Pharmaceutical Dutasteride Drug Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Jiangsu Wangao Pharmaceutical Dutasteride Drug Product Portfolio
6.16.5 Jiangsu Wangao Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dutasteride Drug Industry Chain Analysis
7.2 Dutasteride Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dutasteride Drug Production Mode & Process
7.4 Dutasteride Drug Sales and Marketing
7.4.1 Dutasteride Drug Sales Channels
7.4.2 Dutasteride Drug Distributors
7.5 Dutasteride Drug Customers
8 Dutasteride Drug Market Dynamics
8.1 Dutasteride Drug Industry Trends
8.2 Dutasteride Drug Market Drivers
8.3 Dutasteride Drug Market Challenges
8.4 Dutasteride Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Dutasteride Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Dutasteride Drug Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Dutasteride Drug Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Dutasteride Drug Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Dutasteride Drug Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Dutasteride Drug Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Dutasteride Drug Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Dutasteride Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Dutasteride Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dutasteride Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dutasteride Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Dutasteride Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dutasteride Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dutasteride Drug as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dutasteride Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Dutasteride Drug Sales by Region (2019-2024) & (K Units)
 Table 18. Global Dutasteride Drug Sales Market Share by Region (2019-2024)
 Table 19. Global Dutasteride Drug Sales by Region (2025-2030) & (K Units)
 Table 20. Global Dutasteride Drug Sales Market Share by Region (2025-2030)
 Table 21. Global Dutasteride Drug Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Dutasteride Drug Revenue Market Share by Region (2019-2024)
 Table 23. Global Dutasteride Drug Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Dutasteride Drug Revenue Market Share by Region (2025-2030)
 Table 25. North America Dutasteride Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Dutasteride Drug Sales by Country (2019-2024) & (K Units)
 Table 27. North America Dutasteride Drug Sales by Country (2025-2030) & (K Units)
 Table 28. North America Dutasteride Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Dutasteride Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Dutasteride Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Dutasteride Drug Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Dutasteride Drug Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Dutasteride Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Dutasteride Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Dutasteride Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Dutasteride Drug Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Dutasteride Drug Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Dutasteride Drug Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Dutasteride Drug Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Dutasteride Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Dutasteride Drug Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Dutasteride Drug Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Dutasteride Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Dutasteride Drug Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Dutasteride Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Dutasteride Drug Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Dutasteride Drug Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Dutasteride Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Dutasteride Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Dutasteride Drug Sales (K Units) by Type (2019-2024)
 Table 51. Global Dutasteride Drug Sales (K Units) by Type (2025-2030)
 Table 52. Global Dutasteride Drug Sales Market Share by Type (2019-2024)
 Table 53. Global Dutasteride Drug Sales Market Share by Type (2025-2030)
 Table 54. Global Dutasteride Drug Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Dutasteride Drug Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Dutasteride Drug Revenue Market Share by Type (2019-2024)
 Table 57. Global Dutasteride Drug Revenue Market Share by Type (2025-2030)
 Table 58. Global Dutasteride Drug Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Dutasteride Drug Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Dutasteride Drug Sales (K Units) by Application (2019-2024)
 Table 61. Global Dutasteride Drug Sales (K Units) by Application (2025-2030)
 Table 62. Global Dutasteride Drug Sales Market Share by Application (2019-2024)
 Table 63. Global Dutasteride Drug Sales Market Share by Application (2025-2030)
 Table 64. Global Dutasteride Drug Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Dutasteride Drug Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Dutasteride Drug Revenue Market Share by Application (2019-2024)
 Table 67. Global Dutasteride Drug Revenue Market Share by Application (2025-2030)
 Table 68. Global Dutasteride Drug Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Dutasteride Drug Price (US$/Unit) by Application (2025-2030)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. GSK Dutasteride Drug Product
 Table 74. GSK Recent Developments/Updates
 Table 75. Waylis Therapeutics Company Information
 Table 76. Waylis Therapeutics Description and Business Overview
 Table 77. Waylis Therapeutics Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Waylis Therapeutics Dutasteride Drug Product
 Table 79. Waylis Therapeutics Recent Developments/Updates
 Table 80. Endo Company Information
 Table 81. Endo Description and Business Overview
 Table 82. Endo Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Endo Dutasteride Drug Product
 Table 84. Endo Recent Developments/Updates
 Table 85. Zydus Company Information
 Table 86. Zydus Description and Business Overview
 Table 87. Zydus Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Zydus Dutasteride Drug Product
 Table 89. Zydus Recent Developments/Updates
 Table 90. Aurobindo Pharma Company Information
 Table 91. Aurobindo Pharma Description and Business Overview
 Table 92. Aurobindo Pharma Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Aurobindo Pharma Dutasteride Drug Product
 Table 94. Aurobindo Pharma Recent Developments/Updates
 Table 95. Barr Pharmaceuticals Company Information
 Table 96. Barr Pharmaceuticals Description and Business Overview
 Table 97. Barr Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Barr Pharmaceuticals Dutasteride Drug Product
 Table 99. Barr Pharmaceuticals Recent Developments/Updates
 Table 100. Chartwell Company Information
 Table 101. Chartwell Description and Business Overview
 Table 102. Chartwell Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Chartwell Dutasteride Drug Product
 Table 104. Chartwell Recent Developments/Updates
 Table 105. Amneal Pharmaceuticals Company Information
 Table 106. Amneal Pharmaceuticals Description and Business Overview
 Table 107. Amneal Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Amneal Pharmaceuticals Dutasteride Drug Product
 Table 109. Amneal Pharmaceuticals Recent Developments/Updates
 Table 110. Strides Pharma Company Information
 Table 111. Strides Pharma Description and Business Overview
 Table 112. Strides Pharma Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Strides Pharma Dutasteride Drug Product
 Table 114. Strides Pharma Recent Developments/Updates
 Table 115. Acella Pharmaceuticals Company Information
 Table 116. Acella Pharmaceuticals Description and Business Overview
 Table 117. Acella Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Acella Pharmaceuticals Dutasteride Drug Product
 Table 119. Acella Pharmaceuticals Recent Developments/Updates
 Table 120. Ascent Pharmaceuticals Company Information
 Table 121. Ascent Pharmaceuticals Description and Business Overview
 Table 122. Ascent Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Ascent Pharmaceuticals Dutasteride Drug Product
 Table 124. Ascent Pharmaceuticals Recent Developments/Updates
 Table 125. Humanwell Puracap Company Information
 Table 126. Humanwell Puracap Description and Business Overview
 Table 127. Humanwell Puracap Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Humanwell Puracap Dutasteride Drug Product
 Table 129. Humanwell Puracap Recent Developments/Updates
 Table 130. Sichuan Gowell Pharmaceutical Company Information
 Table 131. Sichuan Gowell Pharmaceutical Description and Business Overview
 Table 132. Sichuan Gowell Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Sichuan Gowell Pharmaceutical Dutasteride Drug Product
 Table 134. Sichuan Gowell Pharmaceutical Recent Developments/Updates
 Table 135. Chengdu Suncadia Medicine Company Information
 Table 136. Chengdu Suncadia Medicine Description and Business Overview
 Table 137. Chengdu Suncadia Medicine Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Chengdu Suncadia Medicine Dutasteride Drug Product
 Table 139. Chengdu Suncadia Medicine Recent Developments/Updates
 Table 140. Qilu Pharmaceutical Company Information
 Table 141. Qilu Pharmaceutical Description and Business Overview
 Table 142. Qilu Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Qilu Pharmaceutical Dutasteride Drug Product
 Table 144. Qilu Pharmaceutical Recent Developments/Updates
 Table 145. Jiangsu Wangao Pharmaceutical Company Information
 Table 146. Jiangsu Wangao Pharmaceutical Description and Business Overview
 Table 147. Jiangsu Wangao Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Jiangsu Wangao Pharmaceutical Dutasteride Drug Product
 Table 149. Jiangsu Wangao Pharmaceutical Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Dutasteride Drug Distributors List
 Table 153. Dutasteride Drug Customers List
 Table 154. Dutasteride Drug Market Trends
 Table 155. Dutasteride Drug Market Drivers
 Table 156. Dutasteride Drug Market Challenges
 Table 157. Dutasteride Drug Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dutasteride Drug
 Figure 2. Global Dutasteride Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Dutasteride Drug Market Share by Type: 2023 & 2030
 Figure 4. Single Drug Product Picture
 Figure 5. Combination Preparation Product Picture
 Figure 6. Global Dutasteride Drug Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Dutasteride Drug Market Share by Application: 2023 & 2030
 Figure 8. Hospital Pharmacy
 Figure 9. Retail Pharmacy
 Figure 10. Online Pharmacy
 Figure 11. Global Dutasteride Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Dutasteride Drug Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Dutasteride Drug Sales (2019-2030) & (K Units)
 Figure 14. Global Dutasteride Drug Average Price (US$/Unit) & (2019-2030)
 Figure 15. Dutasteride Drug Report Years Considered
 Figure 16. Dutasteride Drug Sales Share by Manufacturers in 2023
 Figure 17. Global Dutasteride Drug Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Dutasteride Drug Players: Market Share by Revenue in Dutasteride Drug in 2023
 Figure 19. Dutasteride Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Dutasteride Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Dutasteride Drug Sales Market Share by Country (2019-2030)
 Figure 22. North America Dutasteride Drug Revenue Market Share by Country (2019-2030)
 Figure 23. United States Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Dutasteride Drug Sales Market Share by Country (2019-2030)
 Figure 26. Europe Dutasteride Drug Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Dutasteride Drug Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Dutasteride Drug Revenue Market Share by Region (2019-2030)
 Figure 34. China Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Dutasteride Drug Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Dutasteride Drug Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Dutasteride Drug Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Dutasteride Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Dutasteride Drug by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Dutasteride Drug by Type (2019-2030)
 Figure 53. Global Dutasteride Drug Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Dutasteride Drug by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Dutasteride Drug by Application (2019-2030)
 Figure 56. Global Dutasteride Drug Price (US$/Unit) by Application (2019-2030)
 Figure 57. Dutasteride Drug Value Chain
 Figure 58. Dutasteride Drug Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India